Herantis, whose stock has doubled recently, PRs articles like this one on CDNF, yet we get equally compelling articles about MANF and its up to board members like myself to 'PR' them. For those just seeing this post, I am referring to new article in Experimental Neurology: "Long Term Protective Effects of AAV9-MANF Gene Transfer in the Parksonian Rat." Google it. I have the full copy of article and it is extremely encouraging. http://herantis.com/release/scientific-public...lzheimers/